focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Beiersdorf Implements Sopheon System in Support of Product Innovation Strategy

16 Oct 2007 14:38

Sopheon, the international software and services company,announced today that Beiersdorf AG, a leading manufacturer of skin andbeauty care products, has deployed Sopheon's Accolade product lifecycle management (PLM) system to support the company's implementationof an enhanced, integrated process for developing and launching newproducts. The solution is also being used to strengthen productportfolio decision-making and reporting. £ Founded in Hamburg, Germany in 1882 by pharmacist Carl Beiersdorf,Beiersdorf's original product patents were for bandages and woundcoverings. By the turn of the century, the company had expanded intoconsumer skin care and beauty products. Today Beiersdorf is a $7Bglobal producer of regionally branded consumer goods withapproximately 100 locations and more than 17,000 employees. Thecompany has a reputation for strong customer and product focus, anorientation that has helped, for instance, make NIVEA(R) thebest-selling body care brand in the world. £ Cosmetics is a highly competitive, global industry. It is alsoamong the fastest-moving markets in the consumer goods sector. Thelife of a typical cosmetic product is only about four years, whichmeans that ongoing, rapid innovation is a prerequisite to achievingsustained business growth. Beiersdorf is addressing this imperative asa core aspect of its consumer business strategy, labeled "Passion forSuccess." The strategy calls for the company to focus on fewer butmore significant innovations and deliver them to market faster.Beiersdorf has long regarded continuous improvement of its new productdevelopment processes as a key factor in maintaining brandsuperiority. £ Beiersdorf's adoption of Accolade has allowed the company toadvance not only its processes for product creation, but its portfoliomanagement capabilities as well. One principal benefit of the systemis that it has given the cross-functional teams engaged in productdevelopment across the Beiersdorf organization a common platformthrough which to access and share project data. The result has beengreater transparency and an improved ability to track the progress ofprojects in the developmental pipeline. Accolade has also helped toraise the efficiency and accuracy of portfolio reporting andstrengthen the company's portfolio management and decision-makingprocesses. £ Sopheon partners, Sopheon Vertriebs GmbH and Sopheon BusinessApplications GmbH, were responsible for the sale, implementation andsupport of Accolade at Beiersdorf. Dieter Jaeger, chief executiveofficer of Sopheon Vertriebs GmbH, said, "Beiersdorf has commanded atop position in the international personal care market for many years,and innovation-led product development has been a hallmark of theirsuccess. When we were introduced to Beiersdorf, they already had inplace a standardized, global product development process anchored inbest practices. With Accolade, we were able to give them a single,user-friendly software system that integrated the management of thatprocess with portfolio management and comprehensive decision-support.Beiersdorf chose Accolade because it could match their specific,demanding process requirements. They have subsequently embraced itbecause it has proven that it helps to ensure superior processperformance." £ Accolade(R) is a registered trademark of Sopheon plc. £ NIVEA(R) is a registered trademark of Beiersdorf AG. £ All other trademarks and registered trademarks are the soleproperty of their respective owners. £ About Beiersdorf AG £ Founded in Hamburg, Germany in 1882 as a small pharmacy,Beiersdorf has grown to become a global company of branded consumergoods with approximately 100 affiliates. Since its founding,Beiersdorf has concentrated on skin and beauty care. Beiersdorf isfocused on dynamic regions that have above-average developmentalpotential, including Asia, South America and Eastern Europe.Beiersdorf is particularly focused on China, Russia, Brazil and India.Beiersdorf products include NIVEA(R), Eucerin(R), Curad(R),Labello(R), 8x4(R), JUVENA(R), la prairie(R), atrix(R) and FUTURO(R).For more information, please visit www.beiersdorf.com. £ About Sopheon £ Sopheon (LSE:SPE) is an international provider of software andservices that help organizations improve the business impact ofproduct innovation. Sopheon's solutions automate and govern theinnovation process, enabling companies to increase revenue and profitsfrom new products. Sopheon is listed on the AIM Market of the LondonStock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. Copyright Business Wire 2007
Date   Source Headline
3rd Nov 202310:15 amRNSForm 8.5 (EPT/NON-RI)
3rd Nov 20238:54 amRNSForm 8.3 - Rivomore Limited - Sopheon plc
2nd Nov 20239:34 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20233:44 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 Apex Fundrock Limited Re: Sopheon PLC
1st Nov 20231:55 pmRNSForm 8.3 - Sopheon plc
1st Nov 202311:23 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 202310:51 amGNWForm 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
1st Nov 202310:35 amRNSForm 8.3 - Sopheon PLC
31st Oct 20231:00 pmRNSStatement re Possible Offer
24th Aug 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSAcquisition
15th Jun 20235:06 pmRNSIssue of Equity
8th Jun 20231:35 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Statement
13th Apr 20234:20 pmRNSIssue of Equity
31st Mar 20239:14 amRNSIssue of Equity
27th Mar 20234:23 pmRNSDirector Shareholdings
24th Mar 20237:00 amRNSDirector Share Purchases
23rd Mar 20237:00 amRNSFinal Results
22nd Feb 20234:59 pmRNSIssue of Equity
6th Feb 20237:00 amRNSDirectorate Change and Notice of Results
30th Jan 20237:00 amRNSTrading Update
20th Sep 202212:01 pmRNSSopheon launches Acclaim Line of SaaS Offerings
2nd Sep 202210:06 amRNSIssue of Equity
1st Sep 20227:00 amRNSNew Release of Award-winning Innovation Product
24th Aug 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSFive-year, $11.2m Enterprise Agreement
3rd Aug 202210:18 amRNSHolding(s) in Company
21st Jun 202212:20 pmRNSHolding(s) in Company
9th Jun 20222:30 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
6th Jun 20226:02 pmRNSIssue of Equity & TVR
23rd May 20227:00 amRNSDirector Dealing & Issue of Equity
18th May 20227:00 amRNSAcquisition
29th Apr 20225:12 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSNew Sopheon Software Release
1st Apr 202212:10 pmRNSDirector Shareholdings
24th Mar 20227:00 amRNSFinal Results
25th Jan 20227:00 amRNSTrading Update
17th Jan 20223:15 pmRNSIssue of Equity
20th Dec 20217:00 amRNSAcquisition and Trading Update
24th Sep 20211:52 pmRNSIssue of Equity
16th Sep 202110:00 amRNSHolding(s) in Company
13th Sep 20215:24 pmRNSIssue of Equity
31st Aug 20216:14 pmRNSDirector Shareholdings
25th Aug 20217:00 amRNSInterim Results
13th Jul 20217:00 amRNSNew Release Drives Business Transformation
23rd Jun 20217:00 amRNSSopheon Earns Authority to Operate for NAVSEA
15th Jun 20219:54 amRNSIssue of Equity
10th Jun 202111:43 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.